Locations:
Search IconSearch
November 10, 2017/Ophthalmology/News & Insight

Cole Eye Institute Chair Daniel Martin, MD, Delivers Prestigious Edward Jackson Memorial Lecture

Major address at American Academy of Ophthalmology Meeting

Daniel F. Martin, MD

Daniel F. Martin, MD, Chair of Cleveland Clinic’s Cole Eye Institute, delivers the 74th Edward Jackson Memorial Lecture at the annual meeting of the American Academy of Ophthalmology in New Orleans on Sunday, Nov. 12, at 9:30 a.m.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Dr. Martin, the Barbara and A. Malachi Mixon III Institute Chair in Ophthalmology and Professor of Ophthalmology in the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, will speak on the “Evolution of Intravitreal Therapy for Retinal Diseases: From CMV to CNV.”

Dr. Martin has been Chair of Cole Eye Institute since 2008. Prior to that, he served as Thomas M. Aaberg Professor of Ophthalmology and tenured professor at Emory University School of Medicine in Atlanta.

His clinical interests include both medical and surgical treatments of the retina. Dr. Martin has extensive experience in the management of age-related macular degeneration (AMD), diabetic retinopathy, macular pucker, macular hole, retinal detachment, and inflammatory and infectious diseases of the retina.

A focus on clinical trials

Dr. Martin’s primary research interest is in clinical trials and the evaluation of new treatments for retinal diseases. He serves as the Study Chair for the Comparison of AMD Treatments Trials (CATT) and also serves as the Network Chair for the Diabetic Retinopathy Clinical Research Network (DRCR). He has previously served as Principal Investigator for many AMD, diabetes and uveitis trials, including Age-Related Eye Disease Study (AREDS), Studies of the Ocular Complications of AIDS (SOCA) and Multicenter Uveitis Steroid Treatment Trial (MUST), and has served on numerous data and safety monitoring boards and steering committees.

Dr. Martin was extensively involved in the development of the ganciclovir implant and later valganciclovir for the treatment of cytomegalovirus (CMV) retinitis, serving as Study Chair for the clinical trials that resulted in FDA approval of both drugs.

Advertisement

He has published more than 180 peer-reviewed articles, delivered 28 named lectures and delivered more than 320 invited lectures. Dr. Martin has been the recipient of numerous awards in addition to the Jackson Memorial Lecture: the Senior Honor Award and Secretariat Award from the AAO; the Pyron Award; the Crystal Apple Award and Senior Honor Award from the American Society of Retina Specialists (ASRS); the Rosenthal Award and the Gass Medal from the Macula Society; the Sam and Maria Miller Award for Scientific Achievement in Clinical Research from the Cleveland Clinic; and the Cless Medal. Dr. Martin has previously served on the Board of Governors for the Cleveland Clinic.

Dr. Martin completed medical school at The Johns Hopkins University School of Medicine followed by residency and chief residency in ophthalmology at Emory University School of Medicine. He completed a fellowship in vitreoretinal surgery and diseases at Duke University Eye Center followed by a two-year fellowship in uveitis and ocular immunology at the National Eye Institute, National Institutes of Health.

Jackson Lecture online next year

Dr. Martin’s Edward Jackson Memorial Lecture will be published by the American Journal of Ophthalmology in 2018. This prestigious lectureship is given each year in memory of Edward Jackson, MD, (1856-1942), a pioneer in physiological optics and ophthalmology education and first editor-in-chief of the American Journal of Ophthalmology.

See you in New Orleans

Cole Eye Institute staff members look forward to seeing you at AAO, at our booth and at courses, lectures and symposia, and to sharing lively discussions on latest advances in eye diagnostics, treatment and research – all in our shared effort to improve eyesight for patients. Booth 5332.

Advertisement

Follow Cole Eye Institute on Twitter @CleClinicMD. Live-tweet #AAO2017 with Cleveland Clinic ophthalmologists.

Advertisement

Related Articles

The Featured Image for the post
November 14, 2023/Ophthalmology/News & Insight
The Art of Ophthalmic Imaging

Cole Eye Institute imaging specialists are equal parts technician, artist and diagnostician

The Featured Image for the post
September 22, 2022/Ophthalmology/News & Insight
Unlocking the Potential of OCT: From Imaging to Biomarker Discovery

Innovative work earns ASRS and Macula Society awards for Justis P. Ehlers, MD

21-EYE-24668437-Education Residency Prog – Talcoltt CQD-NEW
November 4, 2021/Ophthalmology/News & Insight
Ophthalmology Residency Program Expands to Four Years, Five Residents

Former internship year now includes specialization in eye care

20-EYE-1875113-IOLs-CQD-4
Higher Order Aberrations and IOL Customization

The art of refractive cataract surgery

18-EYE-4207-DRIL-CQD-Feat
Predicting Visual Acuity Response to Anti-VEGF Therapy in Macular Edema Secondary to Retinal Vein Occlusion

Is disorganization of retinal inner layers (DRIL) a useful prognostic indicator?

18-EYE-1206-Singh-CQD
Cole Eye Physician to Present American Society of Retina Specialists President’s Award Lecture

ASRS recognizes Rishi P. Singh, MD, for work in diabetic eye disease

AAO 2017
November 9, 2017/Ophthalmology/News & Insight
Connect with Cole Eye Institute at AAO 2017

Presentations not to miss, beginning with Jackson Memorial Lecture, plus a lively booth

Ad